RDGL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 22:59):

Stats
Dzisiejszy wolumen	2.76M
Średni wolumen	855 399
Kapitalizacja rynkowa	58.48M
EPS	$0 ( 2024-03-12 )
Następna data zysków	( $0 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.00
ATR14	$0.00300 (2.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-13	Korenko Michael K	Buy	100 000	Common Stock
2023-10-18	Korenko Michael K	Buy	100 000	Common Stock
2023-03-24	Pollack Michael H	Sell	16 000	Common Stock
2022-12-15	Korenko Michael K	Buy	100 000	Common Stock
2022-11-17	Korenko Michael K	Buy	200 000	Common Stock

INSIDER POWER
94.77
Last 83 transactions
Buy: 210 253 762 \| Sell: 27 739 077

Wolumen Korelacja

Długi: 0.12 (neutral)

Krótki: 0.26 (neutral)

Signal:(54.869) Neutral

Vivos Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vivos Inc. Korelacja - Waluta/Towar

-0.52
( weak negative )

0.40
( neutral )

0.00
( neutral )

0.49
( neutral )

Vivos Inc. Finanse

Annual	2023
Przychody:	$19 500.00
Zysk brutto:	$-287 752 (-1 475.65 %)
EPS:	$-0.00780

FY	2023
Przychody:	$19 500.00
Zysk brutto:	$-287 752 (-1 475.65 %)
EPS:	$-0.00780

FY	2022
Przychody:	$36 499.00
Zysk brutto:	$7 720.00 (21.15 %)
EPS:	$-0.00690

FY	2021
Przychody:	$14 887.00
Zysk brutto:	$2 887.00 (19.39 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

Vivos Inc.

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Aktualne aktualizacje dla Vivos Inc. [RDGL]

Upcoming Earnings Alert